A $3 billion agreement with Regeneron will expand biopharmaceutical production in North Carolina, creating 1,400 jobs by 2031 ...

Analytical Biological Services, Inc. ("ABS Bio" or "the Company"), a 3 Boomerang Capital ("3 Boomerang" or "3BC") portfolio ...

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease ...

Our Bureau, Mumbai Friday, January 2, 2026, 14:00 Hrs [IST] ...

Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of all disease-related deaths in the city in 2025. While chemotherapy remains a major treatment ...

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

“While it’s relatively easy to grow animal cells for mass food production you need to be able to grow them on something cheap ...

An international team of researchers led by Hokkaido University has characterized the unique mechanics that enable Arcella, a ...

As the flu season ramps up, a mutated A(H3N2) strain is already driving outbreaks in Canada, the UK, and Japan. That’s why ...

A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...

Clara Powell, 18, a freshman at the University of Arkansas, regularly meets with a group of peers to discuss the role faith ...

The intestinal epithelium undergoes rapid renewal every 3–5 days, a process driven by intestinal stem cells (ISCs) located at ...